Healthcare Sales & Marketing Network News: HPV

Searching News Database: HPV

HSMN NewsFeed - 30 Jan 2024
BD, Techcyte Announce Strategic Collaboration to Offer AI-Based Digital Cervical Cytology System for Pap Testing
Diagnostics Oncology

HSMN NewsFeed - 19 Oct 2023
Antiva Biosciences Strengthens Leadership with Key New Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Sep 2022
Mallinckrodt Announces Appointment of Lisa French as Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Jul 2022
INOVIO Announces Corporate Reorganization to Reduce Operational Expenses and Focus on Opportunities to Bring the Promise of DNA Medicines to Patients
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Jun 2022
INOVIO Appoints Dr. Michael Sumner, MB BS, MBA as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 May 2022
Alercell Starts to Distribute Human Papilloma Virus (HPV) DNA Test
Diagnostics Product Launch

HSMN NewsFeed - 12 May 2022
BD Launches Fully Automated, High-Throughput Infectious Disease Molecular Diagnostic Platform in the U.S.
Diagnostics FDA Product Launch

HSMN NewsFeed - 20 Jan 2022
BioTheryX Announces Appointment of Sahm Nasseri as Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Dec 2021
BD Expands Fully Automated High-Throughput Molecular Diagnostic Platform for Core Labs
Diagnostics Regulatory

HSMN NewsFeed - 5 Nov 2021
INOVIO Expands Executive Leadership to Prepare for Commercial Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Aug 2021
INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800
Biopharmaceuticals Regulatory

HSMN NewsFeed - 25 Aug 2021
BD Launches Fully Automated High-Throughput Molecular Diagnostic Platform for U.S. Laboratories
Diagnostics Product Launch

HSMN NewsFeed - 17 May 2021
INOVIO Announces Appointment Of Roger Dansey, M.D., to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Jan 2021
DURECT Corporation Appoints Two New Board Members
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 22 Jul 2020
BD receives FDA Approval for HPV Test with Extended Genotyping Capabilities
Diagnostics Oncology FDA

HSMN NewsFeed - 8 Jun 2020
Arbor Vita Launches Open Platform COVID-19 Antibody Test Expanding Access To Higher Quality Diagnostics
Diagnostics Product Launch

HSMN NewsFeed - 25 Mar 2019
Inovio Appoints Global Commercial Leader to its Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 19 Mar 2019
Abbott Announces CE Mark for Alinity(TM) m Diagnostics System and Assays, the Latest in Molecular Technology, to Help Deliver Critical Test Results and Benefits to Patients
Diagnostics Regulatory

HSMN NewsFeed - 10 Dec 2018
Merck KGaA, Darmstadt, Germany Announces FDA Orphan Drug Designation for Bifunctional Immunotherapy M7824 in Biliary Tract Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 8 Aug 2018
SQZ Biotech Completes Oversubscribed $72 Million Series C Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 25 Apr 2018
FDA Approval of ThinPrep(R) Integrated Imager Expands Automated Imaging for Pap Testing to More Labs
Devices Diagnostics Oncology FDA

HSMN NewsFeed - 13 Feb 2018
FDA Approves New HPV Test that Detects and Identifies HPV Genotypes that put Women at High Risk for Cervical Cancer
Diagnostics FDA

HSMN NewsFeed - 5 Feb 2018
Tessa Therapeutics Announces Opening of Recruitment Sites Across the United States for its Phase III Nasopharyngeal Cancer Immunotherapy Trial
Biopharmaceuticals Oncology

HSMN NewsFeed - 25 Jan 2018
Aptima(R) HBV Quant Assay for Quantitation of Hepatitis B Viral Load Receives PMA Approval
Diagnostics FDA

HSMN NewsFeed - 25 Dec 2017
I-Mab Biopharma Signs Licensing Agreement for HyLeukin With Genexine
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 6 Sep 2017
RXi Pharmaceuticals Announces Completion of Enrollment of Phase 2 Clinical Trial with Samcyprone for Cutaneous Warts
Biopharmaceuticals Dermatology

HSMN NewsFeed - 4 May 2017
OBP Medical Launches Expanded Portfolio of Single-Use Lighted Specula at ACOG 2017
Devices Product Launch

HSMN NewsFeed - 19 Apr 2017
Advaxis Appoints Anthony Lombardo as Chief Business Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 17 Apr 2017
New ASTRO Guideline Establishes Standard of Care for Curative Treatment of Oropharyngeal Cancer with Radiation Therapy
Devices Oncology

HSMN NewsFeed - 28 Mar 2017
Antiva Biosciences Closes $22 Million Series C Financing
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 16 Feb 2017
FDA Grants PMA Approval for Hologic's Aptima(R) Hepatitis C Quant Dx Assay
Diagnostics FDA

HSMN NewsFeed - 8 Dec 2016
Agenovir Appoints Industry Veteran Dirk Thye, M.D. As Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Nov 2016
Inovio’s Cancer Immunotherapy (INO-3112) Generates T Cell Immune Responses in Tumor Tissue and Peripheral Blood in Patients with HPV-Associated Head and Neck Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 14 Nov 2016
Vigilant Biosciences Announces New Distribution Partnership Agreements for OncAlert(R) Oral Cancer Product Line for Spain, Portugal and Germany
Diagnostics Oncology Distribution

HSMN NewsFeed - 11 Nov 2016
Bristol-Myers Squibb’s Opdivo(R) (nivolumab) is the First Immuno-Oncology Treatment to Receive FDA Approval Based on Overall Survival in Head and Neck Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 19 Oct 2016
GeneFirst Announces CE Marking and Release of Papilloplex(R) HR-HPV, a PCR Based Molecular Diagnostic Test for Genotyping 14 High Risk Human Papillomaviruses from Cervical and Urine Samples
Diagnostics Regulatory Product Launch

HSMN NewsFeed - 6 Sep 2016
BD Submits Pre-Market Approval Application to FDA for BD Onclarity(TM) HPV Test
Diagnostics FDA

HSMN NewsFeed - 12 Jul 2016
Advaxis Appoints Ranya Dajani as Vice President, Corporate Development
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 2 May 2016
Enhanced Cystoscopy including Blue Light Cystoscopy with Cysview(R)/Hexvix(R) is Recommended in the New AUA/SUO Bladder Cancer Guideline
Biopharmaceuticals Diagnostics Urology Oncology

HSMN NewsFeed - 10 Feb 2016
Cocrystal Pharma Announces In-Licensing of CRISPR Cas Technologies for Hepatitis B Virus and Human Papilloma Virus
Biopharmaceuticals Licensing

HSMN NewsFeed - 20 Jan 2016
Immunotherapy Company PDS Biotechnology Strengthens Senior Management Team, Adds Two Drug Development Executives
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 17 Nov 2015
Vigilant Biosciences Announces Distribution Agreements for OncAlert(TM) Oral Cancer System for Czech Republic and Slovakia, Israel and Baltic Region
Diagnostics Oncology Distribution

HSMN NewsFeed - 16 Nov 2015
Vigilant Biosciences Receives CE Mark for OncAlert(TM) Oral Cancer CD44/Total Protein LAB Test to Aid in Diagnosis of Oral Cancer
Diagnostic Oncology Regulatory

HSMN NewsFeed - 1 Oct 2015
Synthetic Biologics Appoints Raymond Stapleton, PhD, as Senior Vice President, Manufacturing
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Sep 2015
Selecta Biosciences Appoints Earl E. Sands, MD, as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Aug 2015
Inovio Pharmaceuticals Enters Into Strategic Cancer Vaccine Collaboration and License Agreement With MedImmune
Biopharmaceuticals Licensing

HSMN NewsFeed - 26 May 2015
Roche receives FDA clearance for the cobas(R) Cdiff Test to detect Clostridium difficile
Diagnostics FDA

HSMN NewsFeed - 30 Mar 2015
Novan Secures $50 Million Private Financing
Biopharmaceuticals Dermatology Venture Capital

HSMN NewsFeed - 26 Jan 2015
Roche receives FDA clearance for next generation cobas MRSA/SA Test
Diagnostics FDA

HSMN NewsFeed - 17 Dec 2014
Inovio Pharmaceuticals Appoints Zane Yang, M.D. Vice President, Clinical Development, Oncology
Biopharmaceuticlas Oncology Personnel

HSMN NewsFeed - 25 Jul 2014
Guided Therapeutics Files PMA Amendment with FDA for LuViva(R) Advanced Cervical Scan
Devices Diagnostics FDA

HSMN NewsFeed - 24 Apr 2014
FDA Approves Roche's HPV Test for First-Line Primary Screening for Cervical Cancer
Diagnostics Oncology FDA

HSMN NewsFeed - 1 Apr 2014
Inovio Pharmaceuticals Continues Building Its Senior Team With the Appointment of VP of Quality
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 19 Dec 2013
Cancer Genetics, Inc. Strengthens Its Diagnostics Sales Team With Seasoned Industry Leader
Diagnostics Oncology Personnel

HSMN NewsFeed - 28 Oct 2013
Advaxis Appoints Gregory T. Mayes as Chief Operating Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Oct 2013
First urine-based cancer mutation monitoring test available from Trovagene
Diagnostics Oncology Product Launch

HSMN NewsFeed - 20 Aug 2013
Advaxis Appoints Daniel J. O’Connor President and CEO and Elects Dr. James Patton Non-Executive Chairman of the Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 4 Mar 2013
Trovagene Appoints Mark Erlander, Ph.D. as Chief Scientific Officer
Diagnostics Personnel

HSMN NewsFeed - 6 Feb 2013
Guided Therapeutics to Develop Esophageal Cancer Product; Acquires Intellectual Property Rights from Konica Minolta
Devices Oncology Acquisitions

HSMN NewsFeed - 29 Jan 2013
Bionor Pharma Appoints Anker Lundemose as President and Chief Executive Officer
Biopharmaceuticals HIV/AIDS Personnel

HSMN NewsFeed - 23 Jan 2013
Watson Acquires Uteron Pharma SA
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 3 Jan 2013
Advaxis Appoints Daniel J. O'Connor to Senior Vice President, Chief Legal and Business Development Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 Dec 2012
Sirnaomics Advances Its Novel siRNA Therapeutics Against HPV Infection and Cervical Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 28 Nov 2012
Trovagene to Introduce First Urine-Based Molecular Diagnostic Test for Transrenal Cancer Mutation Monitoring
Diagnostics Oncology

HSMN NewsFeed - 16 Oct 2012
Hologic Announces FDA Approval of APTIMA HPV 16 18/45 Genotype Assay for Use on the TIGRIS System
Diagnostics Oncology FDA

HSMN NewsFeed - 9 Oct 2012
Vaxxas Appoints David Hoey as Company’s First CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Oct 2012
Gliknik Raises $4.9 Million In Series B Financing Led By Baxter Ventures
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 25 Sep 2012
Gynecor, a Division of Bostwick Laboratories, Inc., Adds New State-of-the-Art Lab Technology to Help Physicians Identify Patients at Risk for Cervical Cancer, Improve Treatment Decisions
Diagnostics Oncology

HSMN NewsFeed - 25 Jul 2012
Guided Therapeutics and FDA Agree on Plan for LuViva(R) Advanced Cervical Scan PMA
Devices Diagnostics Oncology FDA

HSMN NewsFeed - 18 Jul 2012
Guided Therapeutics Notified of CE Mark Approval for LuViva(R) Advanced Cervical Scan
Devices Diagnostics Oncology Regulatory

HSMN NewsFeed - 8 May 2012
FDA Clears Gen-Probe's PANTHER(R) System for use with APTIMA Combo 2(R) Assay
Diagnostics FDA

HSMN NewsFeed - 1 May 2012
Dr. Carlo Croce joins Trovagene as Scientific Consultant and Member of the Company's Scientific Advisory Board
Diagnostics Personnel

HSMN NewsFeed - 30 Apr 2012
Hologic to Acquire Gen-Probe
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 23 Apr 2012
Keith McCormick Joins Trovagene, Inc. as Head of Commercial Operations
Diagnostics Personnel

HSMN NewsFeed - 17 Apr 2012
QIAGEN Receives FDA Clearances for Rotor-Gene Q MDx Instrument and Compatible Influenza A/B Assay
Diagnostics FDA

HSMN NewsFeed - 27 Mar 2012
Guided Therapeutics Partners with Three Firms to Distribute LuViva(R) Advanced Cervical Scan in Six European Territories
Devices Diagnostics Oncology Distribution

HSMN NewsFeed - 15 Mar 2012
Study Indicates Guided Therapeutics’ LuViva(R) Advanced Cervical Scan Could be used as an Initial Screen for Cervical Cancer
Devices Diagnostics Oncology

HSMN NewsFeed - 16 Feb 2012
GenMark Diagnostics Appoints Dr. Jorge Garces Senior Vice President, Research and Development
Diagnostics Personnel

HSMN NewsFeed - 10 Feb 2012
Stephen Zaniboni Joins Trovagene, Inc. as Chief Financial Officer
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 20 Jan 2012
Guided Therapeutics Provides Update on PMA Application for LuViva(R) Advanced Cervical Scan and Timing for Filing of CE Mark
Devices Diagnostics Oncology FDA Regulatory

HSMN NewsFeed - 15 Dec 2011
Guided Therapeutics Selects Eurosurgical Ltd to Distribute LuViva(TM) Advanced Cervical Scan in the United Kingdom
Devices Oncology Distribution

HSMN NewsFeed - 7 Dec 2011
Antonius Schuh, Ph.D. Joins TrovaGene, Inc. As Chief Executive Officer
Diagnostics Personnel

HSMN NewsFeed - 31 Oct 2011
FDA Approves Gen-Probe's APTIMA(R) HPV Assay, New Molecular Test to Detect Virus that Causes Cervical Cancer
Diagnostics Oncology FDA

HSMN NewsFeed - 7 Sep 2011
TrovaGene, Inc., Announces Worldwide Exclusive Licensing of Assay for Hairy Cell Leukemia
Diagnostics Licensing Oncology

HSMN NewsFeed - 19 Jul 2011
Roche acquires mtm laboratories AG, expanding offering in cervical cancer testing
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 1 Jul 2011
Merck Receives Approval to Market GARDASIL(R), ZOLINZA(R) and CUBICIN(R) in Japan
Biopharmaceuticals Regulatory

HSMN NewsFeed - 25 Mar 2011
FDA Approves Zyclara(R) (imiquimod) Cream, 3.75% for the Treatment of External Genital Warts
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Mar 2011
Breakthrough Light-Activated Drug-Device to be Investigated for Treatment of HPV* and Cervical Pre-cancer
Biopharmaceuticals Devices Oncology

HSMN NewsFeed - 7 Mar 2011
Guided Therapeutics Provides Update on FDA PMA Review of Cervical Cancer Test
Devices Diagnostics Oncology FDA

HSMN NewsFeed - 11 Feb 2011
Hologic Receives FDA Approval for First 3-D Digital Mammography (Breast Tomosynthesis) System
Devices Radiology FDA

HSMN NewsFeed - 8 Feb 2011
Hologic Targets Women's Health Professionals at ECR 2011
Devices Radiology Oncology

HSMN NewsFeed - 7 Jan 2011
Hologic Acquires Interlace Medical
Devices Surgery Mergers & Acquisitions

HSMN NewsFeed - 22 Dec 2010
US FDA Approves New Indication for Merck's HPV Vaccine, GARDASIL(R)
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 2 Dec 2010
FDA Accepts Guided Therapeutics' Non-Invasive Cervical Cancer Scanner PMA Application for Review
Devices Diagnostics Oncology FDA

HSMN NewsFeed - 23 Nov 2010
Hologic Receives FDA Approvable Letter for Selenia Dimensions (3-D) Digital Mammography Tomosynthesis System
Devices Radiology Oncology FDA

HSMN NewsFeed - 12 Oct 2010
Dr. Robert Petit Joins Advaxis as V.P. of Clinical Operations
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 27 Sep 2010
Guided Therapeutics Files Premarket Approval Application for Non-Invasive Cervical Cancer Scanner with FDA
Devices Diagnostics Oncology FDA

HSMN NewsFeed - 25 Sep 2010
Hologic's Selenia Dimensions (3-D) Digital Mammography Tomosynthesis System Receives Favorable Votes From FDA Advisory Panel
Devices Radiology Oncology FDA

HSMN NewsFeed - 8 Sep 2010
Jennerex and Transgene Enter Into an Exclusive Partnership for the Development and Commercialization of JX-594 for the Treatment of Cancers
Biopharmaceuticals Oncology

HSMN NewsFeed - 12 Aug 2010
Radient Pharmaceuticals Appoints Gary Giarratano as Director of North American Sales and Marketing
Diagnostics Personalized Medicine Oncology Personnel

HSMN NewsFeed - 8 Jun 2010
IncellDx Secures $3 Million in Series A Financing
Diagnostics Venture Capital

HSMN NewsFeed - 3 Jun 2010
3-V Biosciences Appoints Edward M. Connor, Jr., MD, Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 May 2010
Hologic Unveils Next Generation NovaSure Endometrial Ablation System
Devices

HSMN NewsFeed - 28 Apr 2010
Konica Minolta Opto, Inc. Extends Product Development Licensing Agreement with Guided Therapeutics
Devices Diagnostics Oncology Licensing

HSMN NewsFeed - 25 Mar 2010
Guided Therapeutics LightTouch Cervical Scan FDA Clinical Trial Indicates Adolescent's Risk for Cervical Disease on Par with Adult Women
Devices Diagnostics Oncology

HSMN NewsFeed - 24 Mar 2010
Guided Therapeutics' LightTouch Cervical Scan Detected Disease Up to Two Years Earlier Than Pap, HPV and Biopsy in FDA Pivotal Clinical Trial
Devices Diagnostics Oncology

HSMN NewsFeed - 3 Mar 2010
Abbott to Collaborate With GSK on Molecular Diagnostic Test to Select Candidate Patients for Future Skin Cancer Immunotherapy
Diagnostics Biopharmaceuticals Oncology

HSMN NewsFeed - 25 Feb 2010
Barry Buckland Joins Ancora Pharmaceuticals Board
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Feb 2010
In Phase III Data Merck's GARDASIL(R) Was Efficacious Against Anal Disease Caused by HPV-6,11,16 and 18
Biopharmaceuticals

HSMN NewsFeed - 2 Feb 2010
Guided Therapeutics, Inc. Receives New Funding Commitment from Konica Minolta Opto, Inc. to Expand Cancer Detection Product Line
Devices Diagnostics Oncology

HSMN NewsFeed - 5 Jan 2010
Inovio Appoints Dr. Mark Bagarazzi as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Oct 2009
CDC Advisory Committee Recommends Cervarix To Prevent Cervical Cancer in Girls and Young Women
Biopharmaceuticals Oncology

HSMN NewsFeed - 17 Oct 2009
FDA Approves GARDASIL(R) for Use in Boys and Young Men
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Oct 2009
FDA Approves Cervarix, GlaxoSmithKline's Cervical Cancer Vaccine
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 29 Sep 2009
Hologic Receives CE Marking for the ThinPrep(R) Integrated Imager
Diagnostics Regulatory

HSMN NewsFeed - 9 Sep 2009
FDA Advisory Committee Makes Favorable Recommendation for Cervarix, GlaxoSmithKline's Candidate Cervical Cancer Vaccine
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 1 Sep 2009
FDA Clears Hologic's MammoSite(R) ML Radiation Therapy System for the Treatment of Early-Stage Breast Cancer
Devices Oncology FDA

HSMN NewsFeed - 22 Jul 2009
Profectus Biosciences Secures $5M in Series C Venture Funding
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 6 May 2009
VaxInnate Corporation Closes $30 Million Round of Financing; Wellcome Trust Leads Round
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 13 Mar 2009
FDA Approves Two Hologic HPV Tests
Diagnostics FDA

HSMN NewsFeed - 24 Feb 2009
Imalux(R) Corporation and Preventive Oncology International(R), Inc. Differentiate Grades of Pre-Invasive Cervical Dysplasia with Niris Optical Coherence Tomography Imaging System
Devices Diagnostics Oncology

HSMN NewsFeed - 10 Feb 2009
Guided Therapeutics, Inc. Reports Preliminary Findings from FDA Pivotal Clinical Trial
Devices Diagnostics Oncology

HSMN NewsFeed - 26 Jan 2009
Sequenom Expands Molecular Diagnostics Portfolio with Acquisition of SensiGen
Diagnostics Acquisitions

HSMN NewsFeed - 13 Jan 2009
Abbott Introduces RealTime Molecular Assay in Europe for Detection of HPV Infection
Diagnostics

HSMN NewsFeed - 9 Jan 2009
Merck & Co., Inc. Receives Complete Response Letter from the Food and Drug Administration for Use of GARDASIL(R) in Women Ages 27 through 45
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 13 Nov 2008
GARDASIL®, Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males in Phase III Study
Biopharmaceuticals Oncology

HSMN NewsFeed - 17 Sep 2008
mtm laboratories Launches CINtec(R) Cytology Kit in Europe with Extended Clinical Claims for Cervical Cancer Diagnosis
Diagnostics Regulatory

HSMN NewsFeed - 4 Sep 2008
Guided Therapeutics, Inc. Announces the Appointment of Former Delta Air Lines CEO Ronald W. Allen to Board of Directors
Devices Diagnostics Oncology Personnel

HSMN NewsFeed - 3 Sep 2008
ImClone Submits Supplemental Biologics License Application for ERBITUX(R) in First-Line Head and Neck Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 29 Jul 2008
Advaxis Incorporated Receives List of Questions from the U.S. Food and Drug Administration
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 30 Jun 2008
GlaxoSmithKline Responds to FDA on CERVARIX(R) and Plans to Submit Final Study Data for Approval
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 25 Jun 2008
Merck & Co., Inc Receives Complete Response Letter from the Food and Drug Administration for Use of GARDASIL(R) in Women Ages 27 through 45
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 9 Jun 2008
Hologic to Acquire Third Wave Technologies
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 3 Jun 2008
Gen-Probe Launches Cash Tender Offer to Acquire Belgian Molecular Diagnostics Company Innogenetics
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 30 May 2008
Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
Diagnostics Oncology

HSMN NewsFeed - 28 May 2008
Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
Diagnostics

HSMN NewsFeed - 28 May 2008
Nventa Appoints Gordon H. Busenbark to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 May 2008
Study Finds QIAGEN's HPV Test Offers Greater Long-term Protection from Cervical Disease than the Pap
Diagnostics

HSMN NewsFeed - 14 May 2008
CERVARIX(R) Shown to Provide Longest Duration of Sustained Neutralizing Antibodies to Date
Biopharmaceuticals

HSMN NewsFeed - 2 May 2008
CytoCore Strengthens Sales and Marketing Team
Diagnostics Personnel

HSMN NewsFeed - 21 Apr 2008
Graceway Pharmaceuticals Reports Study in New England Journal of Medicine: ALDARA(R) (imiquimod) Cream, 5% demonstrated a reduction in lesion size in patients with vulvar intraepithelial neoplasia (VIN)
Biopharmaceuticals

HSMN NewsFeed - 3 Apr 2008
AMDL Signs Exclusive Licensing Agreement for Human Papilloma Virus Diagnostic Test Kit in Certain Asian Countries
Diagnostics Licensing

HSMN NewsFeed - 26 Mar 2008
CytoCore Announces Additional International Distribution Agreement
Diagnostics Distribution

HSMN NewsFeed - 19 Mar 2008
Supplemental Application for GARDASIL(R), Merck's Cervical Cancer Vaccine, Designated Priority Review by the U.S. FDA for Use in Women 27 through 45
Biopharmaceuticals

HSMN NewsFeed - 17 Mar 2008
CytoCore Signs First U.S. Distributor for SoftPAP(TM) Cell Collectors
Diagnostics Distribution

HSMN NewsFeed - 10 Mar 2008
GSK Cervical Cancer Candidate Vaccine CERVARIX (R) Demonstrates Long-Term Protection for More Than Six Years
Biopharmaceuticals Oncology

HSMN NewsFeed - 5 Mar 2008
Iverson Genetic Diagnostics Offers FDA Cleared Warfarin Test
Diagnostics FDA

HSMN NewsFeed - 17 Jan 2008
MonoGen Announces Addition of Juan Felix, MD as Medical Director
Diagnostics Personnel

HSMN NewsFeed - 14 Jan 2008
Third Wave Responds to Court Ruling on Anti-Trust Claims in Digene Suit
Diagnostics Litigation

HSMN NewsFeed - 9 Jan 2008
Third Wave Announces Appointment of GE Healthcare Executive Christopher Burton as Senior Vice President of Sales and Marketing
Diagnostics Personnel

HSMN NewsFeed - 8 Jan 2008
Third Wave Announces First European HPV Distribution Partners
Diagnostics Distribution

HSMN NewsFeed - 20 Dec 2007
MedImmune Expands Scientific and Engineering Leadership
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Dec 2007
GlaxoSmithKline Receives FDA 'Complete Response' Letter for Cervical Cancer Vaccine
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 14 Dec 2007
Bradley Pharmaceuticals Launches Veregen(TM) (sinecatechins) Ointment, 15%
Biopharmaceuticals Dermatology

HSMN NewsFeed - 6 Dec 2007
Onset Therapeutics Announces FDA Submission for Novel Product for Topical Treatment of Genital Warts
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 15 Nov 2007
High-price Vaccines Spark Four-fold Growth in Pediatric & Adolescent Vaccines Market
Biopharmaceuticals

HSMN NewsFeed - 6 Nov 2007
Seegene Introduces Only Diagnostic Approach Capable of Detecting Most Prevalent Sexually Transmitted Diseases in a Single Test
Diagnostics

HSMN NewsFeed - 4 Nov 2007
New Data Presented on GARDASIL(R), Merck's Cervical Cancer Vaccine, in Women Through Age 45
Biopharmaceuticals Oncology

HSMN NewsFeed - 30 Oct 2007
New Painless Test for Cervical Cancer Could Provide Access to Better Healthcare for Women Worldwide
Devices Diagnostics Oncology

HSMN NewsFeed - 16 Oct 2007
New Study Shows Listeria Vaccine for Cervical Cancer Found Safe
Biopharmaceuticals Oncology

HSMN NewsFeed - 26 Sep 2007
Merck to Donate Three Million Doses of Gardasil(R), its Cervical Cancer Vaccine, to Support Vaccination Programs in Lowest Income Nations
Biopharmaceuticals Oncology

HSMN NewsFeed - 24 Sep 2007
Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB
Diagnostics Licensing

HSMN NewsFeed - 12 Sep 2007
Nventa Strengthens Management Team With Vice President Of Finance
Biopharmaceuticals Personnel

HSMN NewsFeed - 23 Jul 2007
Court Dismisses Gen-Probe Court Action Against Digene
Diagnostics Litigation

HSMN NewsFeed - 18 Jul 2007
GSK's Cervical Cancer Candidate Vaccine Cervarix(TM) Receives Positive Opinion in Europe for Prevention of Cervical Cancer
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 10 Jul 2007
Cook Medical and Gynecor(TM) Form Strategic Distribution Partnership
Devices Diagnostics Oncology Distribution

HSMN NewsFeed - 27 Jun 2007
Largest Cervical Cancer Vaccine Efficacy Trial Shows CERVARIX(R) Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
Biopharmaceuticals

HSMN NewsFeed - 20 Jun 2007
Merck Provides Update on Status of Supplemental Biologics License Applications (sBLA) for GARDASIL(R)
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 19 Jun 2007
Beckman Coulter, Inc. Dismissed in Case Against Ventana Medical Systems, Inc.
Diagnostics Litigation

HSMN NewsFeed - 19 Jun 2007
Bio-Bridge Science Issues Corporate Update
Biopharmaceuticals

HSMN NewsFeed - 7 Jun 2007
OmniGuide Announces Start of Clinical Trial Comparing the BeamPath Flexible CO2 Laser Fiber to the Pulse Dye Laser
Devices

HSMN NewsFeed - 5 Jun 2007
Nventa hires Vice President of Corporate Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Jun 2007
QIAGEN and Digene Announce Merger Creating Market and Technology Leader In Molecular Diagnostics
Diagnostics Oncology Mergers & Acquisitions

HSMN NewsFeed - 17 May 2007
Data Published in The Lancet Show GARDASIL(R) was 100 Percent Effective in Preventing High-Grade Vulvar and Vaginal Lesions Caused by HPV Types 16 and 18
Biopharmaceuticals

HSMN NewsFeed - 10 May 2007
Preliminary Injunction Denied in Digene's Case Against Ventana Medical Systems
Diagnostics Litigation

HSMN NewsFeed - 9 May 2007
New England Journal of Medicine Publishes New Data on GARDASIL(R), Merck's Cervical Cancer Vaccine
Biopharmaceuticals Oncology

HSMN NewsFeed - 24 Apr 2007
Astrazeneca to Acquire Medimmune for $58 Per Share in a Fully Recommended, All-Cash Transaction with a Total Enterprise Value of $15.2 Billion
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 23 Apr 2007
Hemispherx and Armada Health Care enter Agreement to Launch Alferon N Injection(R) via Specialty Pharmacy Network
Biopharmaceuticals

HSMN NewsFeed - 17 Apr 2007
Merck Submits New Cross-Protection Data for GARDASIL(R) to the FDA and Seeks New Indications for Vaginal and Vulvar Cancers
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 17 Apr 2007
Advaxis Completes Dosing and Enrollment of Third Cohort of Patients in Phase I/II Cervical Cancer Vaccine Trial
Biopharmacetuicals Oncology

HSMN NewsFeed - 16 Apr 2007
SpectRx, Inc. CEO to Retire
Diagnostics Personnel

HSMN NewsFeed - 5 Apr 2007
New Device from LED Dental May Allow Earlier Detection of Oral Cancer
Devices Diagnostics Oncology Dental

HSMN NewsFeed - 28 Mar 2007
Diamics Signs $22 Million Contract With Leading Hospital Group in China
Diagnostics Oncology

HSMN NewsFeed - 22 Mar 2007
CDC Finalizes Advisory Panel Recommendations for GARDASIL(R), Merck's Cervical Cancer Vaccine
Biopharmaceuticals

HSMN NewsFeed - 15 Mar 2007
SpectRx, Inc. Announces Planned Reorganization; Focus on Cervical Cancer Detection
Devices Diagnostics Oncology

HSMN NewsFeed - 5 Feb 2007
Sequenom Names Steven Owings Vice President of Commercial Development, Prenatal Diagnostics
Diagnostics Personnel

HSMN NewsFeed - 30 Jan 2007
SpectRx, Inc. Holds Pre-PMA Meetings with FDA on Painless Cervical Cancer Test
Devices Diagnostics Oncology FDA

HSMN NewsFeed - 18 Jan 2007
GlaxoSmithKline Initiates Head-to-Head Study of Cervical Cancer Vaccines
Biopharmaceuticals

HSMN NewsFeed - 17 Jan 2007
SpectRx, Inc. Announces Management Changes
Diagnostics Personnel

HSMN NewsFeed - 17 Jan 2007
bioMerieux Licenses Technology From Norchip to Launch a HPV Test For Cervical Cancer Risk Detection
Diagnostics Oncology Licensing

HSMN NewsFeed - 10 Jan 2007
Painless Cancer Test May Eliminate Half of Unnecessary Cervical Biopsies
Devices Diagnostics Oncology

HSMN NewsFeed - 5 Jan 2007
Diamics Appoints Christine A. Meda as President
Devices Diagnostics Personnel

HSMN NewsFeed - 20 Dec 2006
CollaGenex Pharmaceuticals Signs License and Supply Agreement with MediGene for Marketing Rights to Oracea in EU and Certain Other Countries
Biopharmaceuticals Dermatology Licensing

HSMN NewsFeed - 6 Dec 2006
Grant Life Sciences hires Kim Liao as Director of Asian Business Development
Diagnostics Personnel

HSMN NewsFeed - 14 Nov 2006
Daryl J. Faulkner Appointed Chief Executive Officer and Director of Digene
Diagnostics Personnel

HSMN NewsFeed - 13 Nov 2006
Merck Launches National Advertising Campaign for GARDASIL(R), Merck's New Cervical Cancer Vaccine
Biopharmaceuticals

HSMN NewsFeed - 7 Nov 2006
Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2007
Devices Biopharmaceuticals Cardiology Oncology Neurology

HSMN NewsFeed - 1 Nov 2006
Merck's Cervical Cancer Vaccine, GARDASIL(R), Added to the CDC Vaccines for Children Contract
Biopharmaceuticals Oncology

HSMN NewsFeed - 30 Oct 2006
Mathematical Model Based on Clinical Findings From Cervarix(TM), GSK's Cervical Cancer Candidate Vaccine, Suggests Vaccination Could Reduce Cervical Cancers by up to 80%
Biopharmaceuticals Oncology

HSMN NewsFeed - 27 Oct 2006
James Godsey, Ph.D., to Join Digene as Senior Vice President Research and Development
Diagnostics Personnel

HSMN NewsFeed - 9 Oct 2006
Pfizer Expands Commitment to Fight Infectious Diseases With Agreement to Acquire Vaccine Company PowderMed Ltd
Biopharmaceuticals Drug Delivery Mergers & Acquisitions

HSMN NewsFeed - 29 Sep 2006
Mathematical Model Predicts That CERVARIX May Prevent Nearly 80 Percent of Cervical Cancers
Biopharmaceuticals Oncology

HSMN NewsFeed - 28 Sep 2006
Carrington Subsidiary to Develop Needle-less Delivery of Cervical Cancer Vaccine With the National Cancer Institute (NCI)
Biopharmaceuticals Drug Delivery Oncology

HSMN NewsFeed - 28 Sep 2006
California to Require Insurers to Cover HPV Testing in Cervical Cancer Screening
Diagnostics Oncology Reimbursement

HSMN NewsFeed - 22 Sep 2006
European Commission Approves GARDASIL(R), Merck's Cervical Cancer Vaccine
Biopharmaceuticals Regulatory

HSMN NewsFeed - 12 Jul 2006
Tigris Pharmaceuticals Completes License Agreements for the Exclusive Rights to Novel, Targeted Cancer Compounds
Biopharmaceuticals Oncology Licensing

HSMN NewsFeed - 12 Jul 2006
Latest Data Confirm GlaxoSmithKline's Proprietary Adjuvant System For Cervarix(TM) Induces a Stronger and More Sustained Immune Response Than a Conventional Adjuvant Formulation
Biopharmaceuticals Oncology

HSMN NewsFeed - 29 Jun 2006
GlaxoSmithKline Applauds ACIP for New Guidance on Use of HPV Vaccine to Protect Girls and Women Against Cervical Cancer
Biopharmaceuticals

HSMN NewsFeed - 29 Jun 2006
Merck's New Cervical Cancer Vaccine, GARDASIL(R), Unanimously Recommended by CDC Advisory Panel for Vaccination of Girls and Women 11 to 26 Years
Biopharmaceuticals Oncology

HSMN NewsFeed - 31 May 2006
Advanced Viral Research (ADVR) Names Abbott Veteran Angelo S. Botter to its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 May 2006
FDA Approves ZOSTAVAX(R), Merck's New Vaccine for Prevention of Shingles in Adults Age 60 and Older
Biopharmaceuticals FDA

HSMN NewsFeed - 24 May 2006
GlaxoSmithKline Demonstrates Progress of Oncology Portfolio; New Data to Be Presented at ASCO 2006
Biopharmaceuticals Oncology

HSMN NewsFeed - 18 May 2006
FDA Advisory Committee Votes Unanimously That Clinical Data Support the Efficacy and Safety of GARDASIL(R), Merck's Investigational Cervical Cancer Vaccine
Biopharmaceuticals Oncology FDA

Return to NewsFeed

Additional items found! 93

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 93 additional stories matching:
HPV
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.